Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | JBJ-09-063 |
Synonyms | |
Therapy Description |
JBJ-09-063 is a fourth-generation allosteric EGFR inhibitor with activity against select EGFR resistance mutations, which potentially results in reduced cell proliferation and tumor growth (PMID: 35422503). |